Life (Jun 2023)

Prediction of Pregnancy-Associated Hypertension Using a Scoring System: A Multicenter Cohort Study

  • Yun Sung Jo,
  • Woo Jeng Kim,
  • Sae Kyung Choi,
  • Su Mi Kim,
  • Jae Eun Shin,
  • Ki Cheol Kil,
  • Yeon Hee Kim,
  • Jeong Ha Wie,
  • Han Wool Kim,
  • Subeen Hong,
  • Hyun Sun Ko

DOI
https://doi.org/10.3390/life13061330
Journal volume & issue
Vol. 13, no. 6
p. 1330

Abstract

Read online

This study aimed to develop an early pregnancy risk scoring model for pregnancy-associated hypertension (PAH) based on maternal pre-pregnancy characteristics, such as mean arterial pressure (MAP), pregnancy-associated plasma protein-A (PAPP-A) or neither. The perinatal databases of seven hospitals from January 2009 to December 2020 were randomly divided into a training set and a test set at a ratio of 70:30. The data of a total pregnant restricted population (women not taking aspirin during pregnancy) were analyzed separately. Three models (model 1, pre-pregnancy factors only; model 2, adding MAP; model 3, adding MAP and PAPP-A) and the American College of Obstetricians and Gynecologists (ACOG) risk factors model were compared. A total of 2840 (8.11%) and 1550 (3.3%) women subsequently developed PAH and preterm PAH, respectively. Performances of models 2 and 3 with areas under the curve (AUC) over 0.82 in both total population and restricted population were superior to those of model 1 (with AUCs of 0.75 and 0.748, respectively) and the ACOG risk model (with AUCs of 0.66 and 0.66) for predicting PAH and preterm PAH. The final scoring system with model 2 for predicting PAH and preterm PAH showed moderate to good performance (AUCs of 0.78 and 0.79, respectively) in the test set. “A risk scoring model for PAH and preterm PAH with pre-pregnancy factors and MAP showed moderate to high performances. Further prospective studies for validating this scoring model with biomarkers and uterine artery Doppler or without them might be required”.

Keywords